Pneumocystis carinii: a fungus resistant to antifungal therapies — mechanisms of action of antipneumocystis drugs

Masur, 1992, Drug therapy: prevention and treatment of pneumocystis pneumonia, N Engl J Med, 327, 1853, 10.1056/NEJM199212243272606 Masur, 1989, NIH conference. Pneumocystis pneumonia: from bench to clinic, Ann Intern Med, 111, 813, 10.7326/0003-4819-111-10-813 Sloand, 1993, The challenge of Pneumocystis carinii culture, J Protozool, 40, 188 Bauer, 1993, Pneumocystis carinii organisms obtained from rats, ferrets, and mice are antigenically different, Infect Immun, 61, 1315, 10.1128/IAI.61.4.1315-1319.1993 Cushion, 1993, Genetic stability and diversity of Pneumocystis carinii infecting rat colonies, Infect Immun, 61, 4801, 10.1128/IAI.61.11.4801-4813.1993 Kovacs, 1989, Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates, J Infect Dis, 159, 1, 10.1093/infdis/159.1.60 Stringer, 1993, The identity of Pneumocystis carinii: not a single protozoan, but a diverse group of exotic fungi, Infect Agents Dis, 2, 109 Lane, 1997, Dihydropteroate synthase polymorphisms in Pneumocystis carinii, J Infect Dis, 175, 482, 10.1093/infdis/175.2.482 Edman, 1988, Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi, Nature, 334, 519, 10.1038/334519a0 Edman, 1994, Molecular phylogeny of Pneumocystis carinii, 91 Haase, 1997, Pneumocystis carinii Delanoe and Delanoe (1912) has been placed in the Archiascomycetales, a class of the Ascomycota, Infect Immun, 65, 4365, 10.1128/IAI.65.10.4365-4366.1997 Bartlett, 1994, Pneumocystis carinii is resistant to imidazole antifungal agents, Antimicrob Agents Chemother, 38, 1859, 10.1128/AAC.38.8.1859 Kaneshiro, 1994, Evidence for the presence of ‘metabolic sterols’ in Pneumocystis: identification and initial characterization of Pneumocystis carinii sterols, J Eukaryot Microbiol, 41, 78, 10.1111/j.1550-7408.1994.tb05938.x Furlong, 1994, Phytosterols are present in Pneumocystis carinii, Antimicrob Agents Chemother, 38, 2534, 10.1128/AAC.38.11.2534 Kaneshiro, 1994, Isoprenoid metabolism in Pneumocystis carinii, J Eukaryot Microbiol, 41, 93S Kaneshiro, 1996, Identification of C31 and C32 sterols in Pneumocystis carinii hominis-infected human lungs, J Eukaryot Microbiol, 43, 36S, 10.1111/j.1550-7408.1996.tb04972.x Urbina, 1997, Inhibitors of delta24(25) sterol methyltransferase block sterol synthesis and cell proliferation in Pneumocystis carinii, Antimicrob Agents Chemother, 41, 1428, 10.1128/AAC.41.7.1428 Debono, 1994, Antibiotics that inhibit fungal cell wall development, Annu Rev Microbiol, 48, 471, 10.1146/annurev.mi.48.100194.002351 Graybill, 1996, The future of antifungal therapy, Clin Infect Dis, 22, S166, 10.1093/clinids/22.Supplement_2.S166 Kovacs, 1993, Multiple genes encode the major surface glycoprotein of Pneumocystis carinii, J Biol Chem, 268, 6034, 10.1016/S0021-9258(18)53422-0 Bartlett, 1996, Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo, Antimicrob Agents Chemother, 40, 1811, 10.1128/AAC.40.8.1811 Morris, 1994, Pneumocandin D0, a new antifungal agent and potent inhibitor of Pneumocystis carinii, J Antibiot (Tokyo), 47, 755, 10.7164/antibiotics.47.755 Schmatz, 1991, Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329, J Protozool, 38, 151S Kurtz, 1995, Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis, Antimicrob Agents Chemother, 39, 1784, 10.1128/AAC.39.8.1784 Kurtz, 1996, Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies, Infect Immun, 64, 3244, 10.1128/IAI.64.8.3244-3251.1996 Lopez, 1987, Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme, J Bacteriol, 169, 4320, 10.1128/jb.169.9.4320-4326.1987 Fermer, 1995, Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species, J Bacteriol, 177, 4669, 10.1128/jb.177.16.4669-4675.1995 Kazanjian, 1997, Pneumocystis carinii mutations associated with sulfa prophylaxis failure in AIDS patients, AIDS Achari, 1997, Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase, Nat Struct Biol, 4, 490, 10.1038/nsb0697-490 Brooks, 1994, Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine, Eur J Biochem, 224, 397, 10.1111/j.1432-1033.1994.00397.x Triglia, 1994, Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum, 91, 7149 Bell, 1991, Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity, Antimicrob Agents Chemother, 35, 1099, 10.1128/AAC.35.6.1099 Bell, 1993, Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition, Antimicrob Agents Chemother, 37, 2668, 10.1128/AAC.37.12.2668 Tidwell, 1993, Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia, Antimicrob Agents Chemother, 37, 1713, 10.1128/AAC.37.8.1713 Dykstra, 1991, Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules, J Protozool, 38, 78S Dykstra, 1994, Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells, Antimicrob Agents Chemother, 38, 1890, 10.1128/AAC.38.9.1890 Fairley, 1993, Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles), J Med Chem, 36, 1746, 10.1021/jm00064a008 Edman, 1989, Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene, 86, 8625 Heffelfinger, 1997, Expression of Pneumocystis carinii major surface glycoprotein in Saccharomyces cerevisiae, J Infect Dis Limper, 1997, Characterization of the Pneumocystis carinii cyclin-cyclin dependent kinase life cycle regulatory system, C13 Russian, 1997, Identification and characterization of novel surface expressed serine protease variants encoded by a multicopy gene family in Pneumocystis carinii, O31 Lugli, 1997, A Pneumocystis carinii multi-gene family with homology to subtilisin-like serine proteases, Microbiology, 143, 2223, 10.1099/00221287-143-7-2223 Edman, 1996, A single expression site with a conserved leader sequence regulates variation of expression of the Pneumocystis carinii family of major surface glycoprotein genes, DNA Cell Biol, 15, 989, 10.1089/dna.1996.15.989 Danner, 1995, A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-I protease. European-Australian Collaborative Ritonavir Study Group, N Engl J Med, 333, 1528, 10.1056/NEJM199512073332303